Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 375 / lenalidomide 20 - Lenalidomide 20 maintenance, indolent B non-Hodgkin Lymphoma induction

Protocol-ID: 329 V1.0 (Mini), RITU375/LENA20 - LENA20 maint., ind. B-NHL Induction

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
  • NHL, B-Cell Type, Follicular Grade I-IIIa; ICD-10 C82.9
  • NHL, B-Cell Type, Indolent
  • NHL, B-Cell Type, Marginal Zone Lymphoma; ICD-10 C83.0
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 23.01.2015